Prognostic value of HE4 in advanced-stage, high-grade serous ovarian cancer: Analysis of HE4 kinetics during NACT, predicting surgical outcome and recurrence in …

A AlSomairi, S Himayda, A Altelmesani, YJ Lee… - Gynecologic …, 2024 - Elsevier
Objectives To assess the prognostic value of human epididymis protein 4 (HE4) kinetics
during and after neoadjuvant chemotherapy (NACT) cycles compared with cancer antigen …
被引用次数：3 相关文章

Prognostic value of HE4 in advanced-stage, high-grade serous ovarian cancer: Analysis of HE4 kinetics during NACT, predicting surgical outcome and recurrence in …

A AlSomairi, S Himayda, A Altelmesani… - Gynecologic …, 2024 - europepmc.org
To assess the prognostic value of human epididymis protein 4 (HE4) kinetics during and
after neoadjuvant chemotherapy (NACT) cycles compared with cancer antigen 125 (CA …

Prognostic value of HE4 in advanced-stage, high-grade serous ovarian cancer: Analysis of HE4 kinetics during NACT, predicting surgical outcome and recurrence in …

A AlSomairi, S Himayda, A Altelmesani… - Gynecologic … - pubmed.ncbi.nlm.nih.gov
Objectives To assess the prognostic value of human epididymis protein 4 (HE4) kinetics
during and after neoadjuvant chemotherapy (NACT) cycles compared with cancer antigen …

Prognostic value of HE4 in advanced-stage, high-grade serous ovarian cancer: Analysis of HE4 kinetics during NACT, predicting surgical outcome and recurrence in …

A AlSomairi, S Himayda… - Gynecologic …, 2024 - gynecologiconcology-online.net
Objectives To assess the prognostic value of human epididymis protein 4 (HE4) kinetics
during and after neoadjuvant chemotherapy (NACT) cycles compared with cancer antigen …